Health Care
Health Care
TheStreet Profiles Dr. Henry Miller on FDA Woes
Ex-FDA Doc: Agency Suffering ‘Unprecedented’ Loss of Trust By Adam Smith Early this year, when the novel coronavirus that was devastating China began to spread to other countries, hope came in the promise of a quick vaccine, one that doctors and scientists bet could be created in just a year and ...
Drug Pricing
Wayne Winegarden Featured in Newsweek Drug Pricing Story
Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
Drug Pricing
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Commentary
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Commentary
Industry Voices—Surprise! There’s a better fix for surprise bills
Federal health officials are trying to reignite the debate over surprise medical bills. In a report issued earlier this summer, the Department of Health and Human Services urged Congress to do something about surprise bills, saying the practice represents a market failure that cannot be corrected on its own. The ...
Commentary
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Commentary
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
Commentary
How Trump can trounce Biden on healthcare
In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Coronavirus
Dr. Henry Miller Explains COVID-19 Air Transmission
Dr. Henry Miller and Lars Larson review the many confusing statements that have come out of the U.S. Center for Disease Control, or CDC, since the start of the coronavirus pandemic. Miller and Larson talk about the recent development that the CDC released around COVID-19 being transmitted in the air, ...
Coronavirus
The Morning Rush Interviews Sally C. Pipes on COVID-19 Reopenings
Sally C. Pipes, PRI’s President and CEO, talks about how shutdowns and shelter in place orders from COVID-19 and the coronavirus are impacting elective procedures and screenings for cancer. Pipes points out that the tremendous delays in elective health care could result in an increase in cancer deaths. Pipes also ...
TheStreet Profiles Dr. Henry Miller on FDA Woes
Ex-FDA Doc: Agency Suffering ‘Unprecedented’ Loss of Trust By Adam Smith Early this year, when the novel coronavirus that was devastating China began to spread to other countries, hope came in the promise of a quick vaccine, one that doctors and scientists bet could be created in just a year and ...
Wayne Winegarden Featured in Newsweek Drug Pricing Story
Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Industry Voices—Surprise! There’s a better fix for surprise bills
Federal health officials are trying to reignite the debate over surprise medical bills. In a report issued earlier this summer, the Department of Health and Human Services urged Congress to do something about surprise bills, saying the practice represents a market failure that cannot be corrected on its own. The ...
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
How Trump can trounce Biden on healthcare
In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Dr. Henry Miller Explains COVID-19 Air Transmission
Dr. Henry Miller and Lars Larson review the many confusing statements that have come out of the U.S. Center for Disease Control, or CDC, since the start of the coronavirus pandemic. Miller and Larson talk about the recent development that the CDC released around COVID-19 being transmitted in the air, ...
The Morning Rush Interviews Sally C. Pipes on COVID-19 Reopenings
Sally C. Pipes, PRI’s President and CEO, talks about how shutdowns and shelter in place orders from COVID-19 and the coronavirus are impacting elective procedures and screenings for cancer. Pipes points out that the tremendous delays in elective health care could result in an increase in cancer deaths. Pipes also ...
